A Study to Investigate the Role of Noncoding RNA miR146 Alpha as a Potential Biomarker in Prostate Cancer
DOI:
https://doi.org/10.30683/1927-7229.2022.11.03Keywords:
Prostate Cancer, Non Coding RNA, miR146 alpha, BiomarkerAbstract
There is a need for additional biomarkers for the diagnosis and prognosis of prostate cancer. MicroRNAs are a class of non-protein coding RNA molecules that are frequently dysregulated in different cancers including prostate cancer and show promise as diagnostic biomarkers and targets for therapy. Here we describe the role of micro RNA 146 a (miR-146a) which may serve as a diagnostic marker for prostate cancer, as indicated from the data presented in this report. Also, a pilot study indicated differential expression of miR-146a in prostate cancer cell lines and tissues from different racial groups. This report provides a novel insight into understanding the prostate carcinogenesis.
References
Chiam K, Ricciardelli C, Bianco-Miotto T. Epigenetic biomarkers in prostate cancer: Current and future uses. Cancer Letters 2014; 342(2): 248-56. https://doi.org/10.1016/j.canlet.2012.02.011
Verma M. Genome-wide association studies and epigenome-wide association studies go together in cancer control. Future Oncol 2016; 12(13): 1645-64. https://doi.org/10.2217/fon-2015-0035
Blute ML, Damaschke NA, Jarrard DF. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications. Curr Opin Urol 2015; 25(1): 83-8. https://doi.org/10.1097/MOU.0000000000000132
Brothman AR, Swanson G, Maxwell TM, et al. Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome? Cancer Genet Cytogenet 2005; 156(1): 31-6. https://doi.org/10.1016/j.cancergencyto.2004.04.004
Mishra A, Verma M. Epigenetics of solid cancer stem cells. Methods Mol Biol 2012; 86: 315-31. https://doi.org/10.1007/978-1-61779-612-8_2
Sethi S, Kong D, Land S, et al. Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer. Am J Transl Res 2013; 5(2): 200-11.
Severi G, Southey MC, English DR, et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat 2014; 148(3): 665-73. https://doi.org/10.1007/s10549-014-3209-y
Shen J, LeFave C, Sirosh I, et al. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas. BMC Med Genomics 2015; 8: 28. https://doi.org/10.1186/s12920-015-0105-1
Smolle M, Uranitsch S, Gerger A, et al. Current status of long noncoding RNAs in human cancer with specific focus on colorectal cancer. Int J Mol Sci 2014; 15(8): 13993-4013. https://doi.org/10.3390/ijms150813993
Czajka AA, Wojcicka A, Kubiak A, et al. Family of microRNA146 Regulates RARbeta in Papillary Thyroid Carcinoma. PLoS One 2016; 11(3): e0151968. https://doi.org/10.1371/journal.pone.0151968
Li H, Xie S, Liu M, et al. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis. Int J Oncol 2014; 45(1): 197-208. https://doi.org/10.3892/ijo.2014.2415
Koppers-Lalic D, Hackenberg M, de Menezes R, et al. Bijnsdorp, Noninvasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles. Oncotarget 2016; 7(16): 22566-78. https://doi.org/10.18632/oncotarget.8124
Kristensen H, Thomsen AR, Haldrup C, et al. Novel diagnostic and prognostic classifiers for prostate cancer identified by genomewide microRNA profiling. Oncotarget 2016; 7(21): 30760-71. https://doi.org/10.18632/oncotarget.8953
Crea F, Venalainen E, Ci X, et al. The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer. Epigenomics 2016; 8(5): 721-31. https://doi.org/10.2217/epi.16.6
Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 2015; 17(6): 816-26. https://doi.org/10.1038/ncb3169
Ye Y, Li SL, Ma YY, et al. Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer. Oncotarget 2017; 8(55): 94834-94849. https://doi.org/10.18632/oncotarget.22014
Wotschofsky Z, Gummlich L, Liep J, et al. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p. PLoS One 2016; 11(2): e0148746. https://doi.org/10.1371/journal.pone.0148746
Li Z, Ma YY, Wang J, et al. Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients. Onco Targets Ther 2016; 9: 139-48. https://doi.org/10.2147/OTT.S95565
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Wenyong Tan, Ming Yang, Yong Dai, Desheng Hu, Geometric Changes in the Parotid, Submandibular, and Thyroid Glands during Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Cohort Study , Journal of Analytical Oncology: Vol. 9 (2020)
- James H. Tabibian, Keith D. Lindor, Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Xiaoyi Liu, Lijuan Deng, Haixia Zhang, Tao Zeng, Hua Wang, Yan Zhang, Secretory Kin17 is Correlated with Chemoresistance in Oral Squamous Cell Carcinoma , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Sayantani Mukherjee, Priya Kalyan Gopal, Santanu Paul , Saurabh Das , Acetylation of 1,2,5,8-tetrahydroxy-9,10-anthraquinone Improves Binding to DNA and Shows Enhanced Superoxide Formation that Explains Better Cytotoxicity on JURKAT T Lymphocyte Cells , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Omar Youssef, Virinder Kaur Sarhadi, Lauri Lehtimäki, Milja Tikkanen, Arto Kokkola, Pauli Puolakkainen, Gemma Armengol, Sakari Knuutila, Mutations by Next Generation Sequencing in Stool DNA from Colorectal Carcinoma Patients - A Literature Review and our Experience with this Methodology , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Augusto Bordim, Beatriz Ferreira de Carvalho Patricio, Michelle Álvares Sarcinelli, Marta de Souza Albernaz, Ralph Santos-Oliveira, Nanoradiopharmaceuticals: Development oF Labeling Process for Polymeric Nanoparticles , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Ximena Camacho, María Fernanda García, Victoria Calzada, Marcelo Fernandez, Omar Alonso, Juan Pablo Gambini, Rodrigo Barbosa de Aguiar, Camila Maria Longo Machado, Roger Chammas, Williams Porcal, Pablo Cabral, 99mTc-Labeled Bevacizumab via HYNIC for Imaging of Melanoma , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Vincent Éthier, Marie-Claude Foley, Sarah Higgins, Régen Drouin, Julie Abel, Rabia Temmar, Rami Kotb, Hans Knecht, Overwhelming Paroxysmal Nocturnal Haemoglobinuria in a Patient with Low-Risk Myelodysplastic Syndrome and Long-Term Anticoagulation for Sick Sinus Syndrome , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Mirel Cabrera, Alejandra Medrano, Nicole Lecot, Marcelo Fernandez, Maria Moreno, Jose A Chabalgoity, Juan Pablo Gambini, Omar Alonso, Henia Balter, Pablo Cabral, A Novel Method to Radiolabel Stealth Liposome through 1,2- dimyristoyl-sn-glycero-3-phosphoethanolamine-N-DTPA with 99mTc and Biological Evaluation , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Mariana Varna, Philippe Bertheau , Luc G. Legrès , Tumor Microenvironment in Human Tumor Xenografted Mouse Models , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
You may also start an advanced similarity search for this article.